Guidelines for Chiropractic Quality Assurance and Practice Parameters aka The Mercy Conference ~ Major Recommendations The Chiropractic Resource Organization
 
   

Guidelines for Chiropractic Quality Assurance
and Practice Parameters


aka The Mercy Conference ~ Major Recommendations

This section is maintained by Frank M. Painter, D.C.
Send all comments or additions to:   Frankp@chiro.org

Chiro.Org is proud to support the FCER and the ICPA and their continuing research into the health benefits of chiropractic care. Please offer them your financial assistance!

 
   

1993 Aspen Publishers, Inc.

Thanks to the National Guideline Clearinghouse™ (NGC), a public resource for evidence-based clinical practice guidelines, for the use of this document!

MAJOR RECOMMENDATIONS:

Jump to:

I.   History and Physical Examination

II.   Diagnostic Imaging

III.   Instrumentation

IV.   Clinical Laboratory

V.   Record Keeping and Patient Consents

VI.   Clinical Impression

VII.   Modes of Care

VIII.   Frequency and Duration of Care

IX.   Reassessment

X.   Outcome Assessment

XI.   Collaborative Care

XII.   Contraindications and Complications

XIII.   Preventive Maintenance Care and Public Health

XIV.   Professional Development

DEFINITIONS

Note from NGC:   The recommendations, presented below, were the most important part of the proceedings. At all times, however, it must be kept in mind that the recommendations should not be perceived as free floating statements. Each recommendation must be placed in the context of the entire document. The scientific and theoretical base of a recommendation must be kept in mind, as well as its relationship to other recommendations. The definitions of the ratings for the documents - the practice rating (e.g., "necessary"), the quality of evidence in support, and the consensus level - are provided in the "Rating Scheme" field of the NGC full summary and are repeated at the end of this major recommendations section. The following excerpt of the major recommendations of the guideline is provided for reference purposes only:

  1. History and Physical Examination:


    1. History

      1. The process by which one determines the diagnosis should be adequately recorded and interpretable.

      2. Rating: Necessary
        Evidence: Class II, III
        Consensus Level: 1
      3. The history plays a critical role in the diagnostic process. A well-performed history will appropriately identify the region to be examined and the extent of the condition.

      4. Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      5. The components of the history may include any or all of the following, dependent on the presentation of the patient and the judgment of the practitioner.

        1. Data on identity, including age and sex

        2. Chief complaint (problem list)

        3. History of present complaint

          • history of trauma

          • description of chief complaint(s)

          • quality/character

          • intensity frequency

          • location and radiation

          • onset

          • duration

          • palliative and provocative factors

        4. Family history

        5. Past health history

          • general state of health

          • prior illness

          • surgical history

          • previous injuries, i.e., MVA, workers’ comp.

          • past hospitalizations

          • previous treatment and diagnostic tests

          • medications

          • allergies

        6. Psycho-social history

          • occupation

          • activities

          • recreational activities

          • exercise

        7. Social history

          • marital status

          • level of education

          • social habits

        8. Review of systems

          • musculoskeletal

          • cardiovascular

          • respiratory

          • gastrointestinal

          • genitourinal

          • central nervous system

          • eye, ear, nose and throat

          • endocrine

          • peripheral vascular disease

          • psychiatric

          Rating: Necessary
          Evidence: Class I, II, III
          Consensus Level: 1
    2. Examination

      1. Practitioners may use any or all diagnostic procedures pertinent to the physical examination, however sophisticated, dependent on individual training and the legal statutory framework within which they work.
        Rating: Necessary
        Evidence: Class II, III
        Consensus Level: 1

      2. Examination procedures regardless of chief complaint(s) may include:

        1. Evaluation of blood pressure and pulse rate

        2. Recording of height and weight

        3. Record of temperature in the presence of pertinent subjective complaints

        Rating: Recommended
        Evidence: Class III
        Consensus Level: 1
      3. In the presence of head complaints evaluation may include examination of the neck and adjacent structures as well as appropriate vascular and cranial nerve testing.
        Rating: Established
        Evidence: Class II, III
        Consensus Level: 1

      4. In the presence of reported or observed changes in cognition, coordination, special sensory function or recent head trauma, it is necessary to perform a neurologic evaluation or obtain a more extensive neurologic/vascular workup in a timely fashion.
        Rating: Established
        Evidence: Class II, III
        Consensus Level: 1

      5. Examination of the neck and adjacent structures may include:

        1. Inspection and observation to include postural presentation of the region

        2. Regional palpation

        3. Range of motion including active and/or passive movement

        4. Muscle strength

        5. Provocative maneuvers which might include compression and stretching

        6. Neurologic examination

        7. Vascular examination

        as is safe and effective in diagnosing the patient.

        Rating: Established
        Evidence: Class II, III
        Consensus Level: 1
      6. Examination procedures for thoracic and/or chest complaints may include:

        1. Inspection and observation to include postural presentation of the region

        2. Regional palpation

        3. Auscultation of the chest in the presence of pertinent subjective complaints to be performed by the practitioner or appropriate specialist

        4. Auscultation of heart sounds in the presence of pertinent subjective complaints to be performed by the practitioner or appropriate specialist

        5. Auscultation and palpation of the abdomen

        6. Range of motion including passive and/or active movements

        7. Muscle strength

        8. Provocative maneuvers which may include compression and stretching

        9. Neurologic examination

        as is safe and effective in diagnosing the patient.

        Rating: Established
        Evidence: Class II, III
        Consensus Level: 1
      7. Examination procedures for lower back and adjacent structures may include:

        1. Inspection and observation to include postural presentation of the region

        2. Regional palpation

        3. Evaluation of the abdominal aorta to include palpation and auscultation in the presence of pertinent subjective and objective findings

        4. Evaluation of the abdominal/pelvic viscera to include palpation and/or auscultation in the presence of pertinent subjective complaints

        5. Range of motion including passive and/or active movements

        6. Muscle strength

        7. Provocative maneuvers which may include compression and stretching

        8. Neurologic examination

        9. ]Vascular examination

        10. Recording the circumference of the involved extremity in the presence of pertinent subjective complaints

        as is safe and effective in diagnosing the patient.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      8. Examination procedures for extremity complaints may include:

        1. Vascular examination

        2. Neurologic examination

        3. Regional palpation

        4. Range of motion including passive and/or active movements

        5. Provocative maneuvers which may include compression and stretching.

        6. Recording the circumference measurements of the involved extremity in the presence of pertinent subjective complaints.

        as is safe and effective in diagnosing the patient.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      9. Independent chiropractic examinations (ICE) should be performed in accordance with the recommendations put forth in this chapter.
        Rating: Recommended
        Evidence: Class II
        Consensus Level: 1


  2. Diagnostic Imaging:


    1. Sequence of Services

      The practitioner, in most instances, is the person that initiates a radiographic study. The study is performed by the technologist or qualified person in a safe environment in a manner consistent with published guidelines regarding quality and performance. It is the standard of care that all studies are viewed for interpretation by the practitioner or radiologist to obtain the maximum level of diagnosis which is achievable based on the type of study performed. Standard and customary billing procedures are followed.

      Rating: Established
      Evidence: Class III
      Consensus Level: 1
    2. Patient Selection Procedures

      The decision on whether or not to use diagnostic imaging studies is made following a carefully performed history, physical and regional evaluation, and consideration of cost/ benefit/radiation exposure ratios. It is based on sound clinical reasoning and the likelihood that significant information can be obtained from the study in regards to diagnosis, prognosis and therapy. The decision remains solely the domain of the examining (primary) practitioner.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1

      Comment:   It is difficult to weigh the impact of the political, litigious, and social climate on the perceived need of many practitioners to have prior radiographic evidence of the area to be manipulated. This issue needs further study before firm conclusions about the prophylactic acquisition of radiographs can be made.

    3. Radiographic Interpretation and Reporting

      Imaging studies are performed primarily to contribute to a diagnostic impression. Interpretation of each imaging study should be documented in the patient’s permanent record.

      Rating: Established
      Evidence: Class II, III
      Consensus Level: 1
    4. Legal Issues in Radiography

      Federal regulations (Public Law 97-35 sec. 978) state that radiography, as applied to chiropractic practice, is used for diagnostic purposes only, and not for radio-therapeutic purposes. The National Council on Radiation Protection has established recommendations for the safe and effective use of radiography. It is the responsibility of every practitioner to be informed of and abide by all relevant legal requirements.

      Rating: Established
      Evidence: Class III
      Consensus Level: 1
    5. Radiation Technology and Protection

      Practitioners should keep the radiation exposure of patients as low as reasonably achievable. This includes use of modem equipment and techniques as outlined in the literature review section of this document. A suboptimal radiograph should be repeated. The decision on whether or not to expose a patient to radiation is only valid before the series is ordered. Once committed to the acquisition of a series, the practitioner is obligated to produce high quality radiographs.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    6. Plain Film Radiographs

      The plain film radiograph is considered an adequate first step in the evaluation of degenerative and inflammatory joint disease, fracture, infection and neoplasm. Not every patient with these conditions will require radiography for diagnosis. Orthogonal views are a necessary minimum for visualizing any body area. Additional views are used as appropriate to demonstrate conditions that could exist given the findings of the clinical diagnosis.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1

      For postural and biomechanical assessment.

      Rating: Promising
      Evidence: Class II, III
      Consensus Level: 1
    7. Full Spine Radiography

      For scoliosis evaluation where indicated by clinical examination.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1

      For evaluation of complex biomechanical or postural disorders and the evaluation of multi-level spinal complaints as a result of biomechanical compensation.

      Rating: Promising
      Evidence: Class II, III
      Consensus Level: 1
    8. Stress Radiography

    9. Stress views are often of value in the assessment of degenerative, traumatic or post-surgical instabilities with the exception of those that carry the risk of neurologic injury. They provide unique diagnostic information.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1

      For other conditions and circumstances.

      Rating: Equivocal
      Evidence: Class II, III
      Consensus Level: 1
    10. Videofluoroscopy (cinefluoroscopy)

      For kinematic and other biomechanical purposes.

      Rating: Promising
      Evidence: Class II, III
      Consensus Level: 1

      Comment:   The authors of the Quebec Task Force (1987) have outlined the limited use criteria that currently appear valid.

      For instability of the wrist and contrast studies.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    11. Plain Film Contrast Studies

      Provide valuable unique information in special circumstances. These studies should only be performed by a radiologist.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    12. Computed Tomography

    13. Valuable in the assessment of most musculoskeletal conditions requiring sectional imaging. Of particular utility in the evaluation of complex fractures in flat bones or the posterior arch of any spinal level. Adequately sensitive and specific for the evaluation of complicated degenerative conditions and herniated nucleus pulposus of the lumbar spine. Ordered only in the presence of specific clinical indications.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    14. Magnetic Resonance Imaging

      The study of choice in the pre-operative evaluation of many internal derangements of articulations, and the evaluation of many central nervous system disorders. Comparisons between CT and MRI have shown similar sensitivity. Limited spatial resolution capabilities and cost are drawbacks. Ordered only in the presence of specific clinical indications.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    15. Radionuclide Bone Scanning

      Has an established role in the evaluation of bone disease. Adequately sensitive, put poorly specific. Ordered only in the presence of specific historical and diagnostic information.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1
    16. Diagnostic Ultrasound

      Utility and accuracy in the evaluation of musculoskeletal conditions remains limited, but diagnostic ultrasound has promise as a non-invasive, inexpensive alternative to MRI and arthrography. An established modality for evaluation of many intra-abdominal and pelvic organs.

      Rating: Established
      Evidence: Class I, II, III
      Consensus Level: 1

  3. Instrumentation:

    Perceptual Measurements

    1. Questionnaires as Instruments

      Questionnaire instruments are safe and effective. Several instruments have been fully validated, are widely used and well established. Their use is supported by both Class I (modified to the discipline of measurement) and Class II evidence.

      Strength of recommendation: Type A.
      Consensus Level: 1

    2. Screening Questionnaire

      Their use is safe and effective, supported by Class II and Ill evidence.

      Strength of recommendation: Type C.
      Consensus Level: 1

    3. Pressure Algometry

      Pressure algometry is safe and effective when contrasted with normative values for region and gender. It is a new procedure that is not yet in wide use but is promising. Its use is supported by Class II and Class III evidence.

      Strength of recommendation: Type B.
      Consensus Level: 1

    Functional Measurements

    1. Measurement of Position/Clinical Anthropometry (Posture)

      1. Plumbline Analysis

        Plumbline analysis is safe and effective when used to assess upright posture. It can be administered by persons with minimal training but should be interpreted by a professional health-care provider. The procedure is widely used, established and supported by both Class II and Class III evidence.

        Strength of recommendation: Type B.
        Consensus Level:1

      2. Scoliometry

        Scoliometry is safe and effective and can be administered by persons with minimal training but should be interpreted by a professional health care provider. The procedure is well established and supported by both Class I and Class II evidence.

        Strength of recommendation: Type A.
        Consensus Level: 1

      3. Photogrammetry Methods

        Photogrammetry methods are safe and effective means to quantify topographical or structural anomaly and work postures. Training is necessary to avoid error sources and assure reliability of measures. The procedures are well established and supported by evidence in Classes I, II and III.

        Strength of recommendation: Type A.
        Consensus Level: 1

      4. Moire Topography

        Moire topography is safe and can be administered by persons with minimal training but requires oversight on technical procedures. It is of limited effectiveness. The procedure is promising only as a qualitative screening method supported by Class II and Class III evidence.

        Strength of recommendation: Type B.
        Consensus Level: 1

      5. Bilateral Weight Distribution

        Bilateral weight scales are safe but their effectiveness is unknown and is rated as equivocal. Class II and III evidence is available.

        Strength of recommendation: Type C.
        Consensus Level: 1

      6. Automated Measurements of Posture

        Automated methods have received limited acceptance and are rated as promising. They are safe to administer but their effectiveness is limited by the training and practice of the operator. Fundamental difficulty in landmark identification and limited information on reliability restricts the use to screening purposes. Their use is supported by Class II and Class III evidence.

        Strength of recommendation: Type B.
        Consensus Level: 1

    2. Measurement of Movement

      1. Goniometers

        Goniometers are widely used, safe and effective. They are established to measure peripheral joint motion although the margin of error remains high. Class I and Class II evidence supports their use.

        Strength of recommendation: Type A.
        Consensus Level: 1

      2. Inclinometers

        Inclinometers are established for measurements of spinal motion. Their common use is supported by Class I and Class II evidence and is safe and effective.

        Strength of recommendation: Type A.
        Consensus Level: 1

      3. Optically Based Systems

        Optically based systems are established for evaluating specific gait abnormalities or risky positions related to work tasks. They are safe and effective when evaluated by specially trained personnel and are supported by Class II evidence.

        Strength of recommendation: Type B.
        Consensus Level: 1

      4. Computer Assisted Range of Motion Systems

        Computer assisted range of motion systems provide improved levels of precision and reproducibility. They are safe, effective and non-invasive. They require specialized training and should be interpreted by a qualified health care provider. Clinical applications are promising. Class II and III evidence is available.

        Strength of recommendation: Type B.
        Consensus Level: 1

    3. Measurement of Strength

      1. Manual Strength Testing

      2. Manual strength testing is widely used, safe and largely ineffective for strength differences less than 35%. Hand held load cells may assist in finding smaller differences in extremity muscle strengths. It is established as a screening procedure and is supported by Class I and Class II data.

        Strength of recommendation: Type A.
        Consensus Level: 1

      3. Isometric Strength Testing

        Isometric strength testing is an established procedure that is effective for limited applications involving employment evaluation and post-injury assessment where relevant standards can be determined. The methods are safe when performed by trained personnel who can make appropriate clinical judgments with respect to patient limitations during the procedure and when contraindications are observed. Class I and Class II data are available.

        Strength of recommendation: Type A.
        Consensus Level: 1

      4. Isokinetic Strength Testing

        Isokinetic strength testing is widely used, safe for non-acute disorders and effective for making bilateral comparisons or contrasting performance to normative data. The procedures are well established in sports applications and promising for post-injury use after the acute phase of treatment has passed. Class II and Class III evidence supports its use.

        Strength of recommendation: Type B.
        Consensus Level: 1

      5. Isoinertial Strength Testing

        Isoinertial strength testing is a promising procedure for employment selection and post-injury applications. It is safe for non-acute disorders when carried out by trained personnel. Class II and Class III evidence has been reported.

        Strength of recommendation: Type C.
        Consensus Level: 1

    Physiologic Measurements

    1. Thermographic Recordings

      1. Thermocouple Devices

        Thermocouple devices are still in use. While they are safe, there is no evidence to support a claim of effectiveness. Their use is rated doubtful and is supported by Class II and Class III evidence.

        Strength of recommendation: Type D.
        Consensus Level: 3

      2. Infrared Thermography

        Infrared thermography is a safe procedure of intense controversial effectiveness. Its use requires specially trained personnel and specially adapted surroundings. Its rating as equivocal/promising is supported by continuing controversy from Class II and Class III evidence.

        Strength of recommendation: Type C because of the controversy.
        Consensus Level: 3

    2. Galvanic Skin Response

      These types of measurement are safe, but generally ineffective as a result of questions remaining on reliability and validity from Class II and Class III types of evidence. For general arousal studies they are considered investigational.

      Strength of recommendation: Type D.
      Consensus Level: 1

      For acupuncture point finding and for assessing spine-related disorders, they are considered as doubtful.

      Strength of recommendation: Type E.
      Consensus Level: 1

    3. Electrophysiologic Recordings

      All of the electrodiagnostic methods are safe when carried out by specially trained personnel. Interpretation should be carried out only by physicians with extensive training in the technical and clinical considerations that can readily confound the findings.

      1. Kinesiologic Surface (Scanning) EMG

        Kinesiologic surface (scanning) EMG is a rapidly proliferating, safe procedure that has not been shown effective with the exception of limited use for flexion/relaxation and mean/ median frequency shifting measures. Generally, its use remains investigational. Specific procedures of flexion/relaxation and mean/median frequency shift evaluation are considered promising based on Class II and Class III evidence.

        Strength of recommendation - scanning surface
        EMG: Type C.
        Consensus Level: 2

        Strength of recommendation - flexion/relaxation and mean/median frequency shift measures: Type B.
        Consensus Level: 1

      2. Surface Electrodiagnostic Procedures (NCV, F-wave, H-Reflex, SSEP)

        Surface electrodiagnostic procedures (NCV, F-wave, H-reflex, SSEP) are established procedures effective for examination of peripheral nerve disorders and are supported by Class I and Class II evidence. Somatosensory evoked potentials are established for limited applications to peripheral nerve disorders and lesions affecting the long sensory tracks of the spinal cord.

        Strength of recommendation: Type A.
        Consensus Level: 1

      3. Needle Electrodiagnostic Procedures (EMG, NCV, F-wave, H-reflex, SSEP)

        Needle electrodiagnostic procedures (EMG, NCV, F-wave, H-reflex, SSEP) are widely used, established procedures that are affective in assessing functional effects of pathology affecting the central and peripheral nervous system and muscle. Class I and Class II evidence is available.

        Strength of recommendation: Type A.
        Consensus Level: 1

      4. Electrocardiography

        ECG is a widely used, safe, effective and established procedure for aiding in the differential diagnosis of complaints that may be cardiopulmonary in origin. Interpretation requires specialized training. Class I and Class II evidence is available.

        Strength of recommendation: Type A.
        Consensus Level: 1

    4. Procedures

      Clinical laboratory testing is an established approach that is widely used, safe and effective when used in differential diagnosis. Test procedures require appropriate technical instrumentation operated by specially trained and certified staff as determined by law. Equipment must be kept calibrated and standardized. Quality assurance procedures must be followed to ensure accuracy and reliability. Class I, II and III evidence is available.

      Strength of recommendation: Type A.
      Consensus Level: I

    5. Other Instrument Measures

      1. Doppler Ultrasound

        Doppler measures are well established, safe and effective as means to quantify the presence of vascular disease. Special training is necessary and a trained health care provider should interpret results. Both Class II and Class III data are available.

        Strength of recommendation: Type B.
        Consensus Level: 1

      2. Plethysmography

        Plethysmography is used on occasion. It is safe and effective when tissue volume changes and a symptom or peripheral vascular differential diagnosis is needed. Use for these purposes is well established. Special training is necessary and a trained health care provider should interpret results. Its effectiveness as a monitor of treatment of spine disorders is not determined and use for this purpose should be considered investigational. Class II and Class III data are available.

        Strength of recommendation - differential diagnosis: Type B.
        Consensus Level: 1

        Strength of recommendation - monitor spine disorders: Type D.
        Consensus Level: 1

      3. Spirometry

        Pulmonary function testing is established as a method to assess effect of severe scoliosis and the differential diagnosis of lung disease. These uses are backed by Class I and Class II evidence. The procedures are safe and effective when performed by appropriately trained personnel.

        Strength of recommendation: Type A.
        Consensus Level: 1


  4. Clinical Laboratory:

    1. General

      1. The Role of Laboratory Procedures in Chiropractic Practice

        The appropriate use of clinical laboratory procedures in chiropractic practice is for diagnosis, screening, and patient management.

        Comment: Clinical laboratory tests are used by the practitioner to (1) aid in the diagnostic process; (2) screen for early recognition of preventable health problems; and (3) monitor patient progress and outcomes. It is inappropriate to utilize clinical laboratory procedures for other purposes (e.g., for defensive testing or economic gain).

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      2. Laboratory Selection

        It is recommended that the practitioner who uses the services of a clinical laboratory should be aware of the laboratory’s scope of services, recognition (licensure and accreditation), and reputation.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      3. Office Laboratories

        The practitioner who performs office laboratory procedures should carry out testing in a manner that meets state and/or federal regulations, and is consistent with quality laboratory practice.

        Comment: State and federal regulations define the scope of testing, qualification of laboratory personnel, and the need and extent of quality assurance and proficiency testing.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      4. Proper Patient Preparation

        The practitioner should make sure the patient is adequately prepared for laboratory testing, verifying that the patient understands any special instructions to assure adequate specimens necessary to generate valid laboratory results.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      5. Specimen Collection and Preservation

        The practitioner should assure that in-office laboratory specimens are appropriately collected and preserved.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      6. The Need for Laboratory Testing

        Laboratory procedures may be appropriate when the information available from the history, clinical examination, and previous evaluation is considered insufficient to address the clinical questions at hand.

        Comment: The decision to order and/or perform a given test or procedure is made on the assumption that the results will appreciably reduce the uncertainty surrounding a given clinical question and significantly change the pre-test probability that the disorder is present.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      7. Laboratory Test Selection in Diagnosis

        The practitioner should select a laboratory test(s) appropriate for the purpose of ruling out a specific condition(s) or confirming a strong clinical suspicion by considering the sensitivity and specificity of the test(s) and estimating the likelihood of the condition(s) (pretest probability) based on his or her assessment of the available clinical information.

        Rating: Promising
        Evidence: Class I, II, III
        Consensus Level: 1
      8. Laboratory Test Selection in Screening

        The use of laboratory tests for screening purposes should include selection of a highly sensitive laboratory test(s) and the appropriate application of the test(s) to health problem(s) which are common, have significant morbidity/mortality and are preventable and/or amenable to effective care.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      9. Laboratory Test Selection in Patient Management (Monitoring)

        The reproducibility (precision) of the test is the most important characteristic when selecting laboratory tests for monitoring.

        Comment: The optimal frequency for monitoring patients cannot be predicted solely on the basis of knowledge of the disorder or the effectiveness of chiropractic care. It requires the application of normal physiology, knowledge of the natural history of the underlying disorder, tests or procedures used to monitor the disorder and awareness of factors other than the disorder that may influence the test results.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      10. Interpretation of Laboratory Reference Values

        The practitioner should have an understanding of "normality" as it applies to conventional laboratory reference values in order to appropriately interpret laboratory results.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      11. Integration of Clinical Laboratory Data with Other Examination Findings

        Clinical laboratory data should be integrated with results from other examinations as part of the clinical decision-making process when monitoring the patient’s clinical status.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      12. Communication of Laboratory Procedures and Results to the Patient

        The practitioner should effectively discuss with the patient the purposes, possible complications, and clinical significance of the results of laboratory studies conducted or ordered.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      13. Recording Laboratory Results:

        Clinical laboratory results should be recorded in the patient case record.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      14. Consultation on Laboratory Procedures

        The practitioner should seek assistance when uncertain about appropriate test selection, patient preparation, and/or interpretation of laboratory results.

        Rating: Established
        Evidence: Class III
        Consensus Level: 1
      15. Use of Focused Organ/Health Problem-Oriented Test Profiles

        The use of profiles which focus on an organ system and/or health problem in a symptomatic patient can be considered a cost-effective and efficient procedure for generating appropriate laboratory data to help confirm or rule out a diagnosis or clinical impression.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      16. Use of Investigational Laboratory Tests

        Laboratory tests which are considered to be investigational should be used in clinical settings only when part of an acceptable research protocol which is supervised by the staff of a recognized research institution.

        Comments: Research protocols for the evaluation of investigational clinical laboratory tests should take into consideration the actual need for the tests, the inherent properties of the tests, the population characteristics to which the tests are applied, the existence of gold standard tests, the required study population size, and the tests’ discrimination abilities relative to sensitivity, specificity, and predictive value (Adams, 1990). Research protocols should be approved by an institutional review board.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      17. The Novel Application of Established Laboratory Procedures in Chiropractic Practice

        Novel application of established laboratory procedures should not be used in chiropractic practice as a substitute for conventional application of laboratory procedures in the clinical decision-making process.

        Comment: Novel applications of established tests should be evaluated by appropriate research methods. If used in a patient care setting, informed consent is necessary.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
    2. Guidelines for Ordering Commonly Utilized Laboratory Procedures

      1. Guidelines for Ordering a Urinalysis

        1. Outpatient Screening/Case-Finding

          i. A urinalysis is not indicated in asymptomatic individuals whose history and physical examination findings are within the normal ranges for age and sex.

          ii. In specific subsets of the population with higher prevalence of renal disease, urinary tract infections, liver disease, and diabetes mellitus, the urinalysis may be useful to identify those who are significantly at risk, including but not limited to the following:

          • Pregnancy

          • Elderly (> 60 years) men and women

          • Obese individuals with a positive family history of diabetes mellitus

          • Individuals taking hepato- or nephrotoxic drugs

          • Individuals routinely exposed to toxic chemicals in the work or home environment

        2. Diagnosis

          i. The urinalysis is indicated in patients where there are clinical findings suggestive of urinary tract infections, renal disease, diabetes mellitus, and liver disease. The urinalysis should include physical, chemical, and microscopic evaluation.

          ii. The urinalysis may be useful in patients with previous positive findings for proteinuria, microhematuria, bacteriuria, pyuria, or diabetes mellitus.

        3. Monitoring

          i. Repeat urinalysis is not indicated in patients in whom no abnormality is suspected.

          ii. Repeat urinalysis may be useful in the following:

          • Documenting evidence of response to treatment for urinary tract infections, renal disease, and diabetes mellitus

          • Patients in whom there is concern that treatment has not been effective

          • Patients taking medications which are hepato- or nephrotoxic

          • Individuals routinely exposed to toxic chemicals

          • Pregnancy

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      2. Guidelines for Ordering a Complete Blood Count (CBC)

        1. Outpatient Screening/Case-Finding

          i. CBCs are not indicated in asymptomatic individuals whose history and physical examination findings are within reference for age and sex.’

          • Routine use of CBCs in populations of low disease prevalence have a low diagnostic yield

          ii. In specific subsets of the population with higher prevalence of anemia, the CBC may be useful to identify those who are significantly anemic because of poor nutrition or undiagnosed chronic illness, including but not limited to the following:

          • Pregnant women in whom there is a suspicion that iron supplementation or nutrition has not been adequate

          • The elderly (>75 years old)

          • Recent immigrants from Third World countries, especially persons at increased risk of malnourishment

          • Individuals on diets which are nutritionally unbalanced

        2. Diagnosis of Suspected Abnormality

          i. The CBC is useful in the diagnosis of infection or primary hematological disorders.

          • The CBC is indicated in patients in whom there are clinical findings suggestive of anemia, including fatigue, mucous-membrane pallor, sore tongue, peripheral neuropathy, abnormal bleeding, or findings suggestive of polycythemia

          ii. The CBC may be useful in conditions that may be associated with anemia and/or abnormal leukocyte counts, such as rheumatoid arthritis, malignancy (e.g., lymphoma)and renal insufficiency.

          iii. The CBC may be useful when fever is present or when infection is suspected, especially when other confirmatory findings are absent.

        3. Monitoring

          i. Repeat CBCs are not indicated in patients in whom no abnormality is suspected.

          ii. Repeat CBCs may be useful in the following:

          • Patients in whom there is concern that treatment has not been effective

          • Documenting evidence of response to treatment for anemia

          • Patients with infection not improving clinically under collaborative care

          • Patients with leukopenia (leukocyte count is less than 4,500/j.d)

          • Patients taking cytotoxic medications

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      3. Guidelines for Ordering the Erythrocyte Sedimentation Rate (ESR) Test

        1. Outpatient Screening/Case-Finding

          i. The ESR is not indicated in asymptomatic persons.

          ii. An ESR should be ordered/performed selectively and interpreted with caution in patients whose symptoms are not adequately explained by a careful history and physical examination.

          • Significant infections or inflammatory or neoplastic disease are unlikely in such patients, and the ESR must be markedly elevated to be diagnostically useful.

          • Extreme elevation of the ESR seldom occurs in patients with no evidence of serious disease.

        2. Diagnosis

          i. The ESR is useful for the diagnosis of temporal arteritis (giant cell arteritis) and polymyalgia rheumatica.

          • A normal ESR virtually excludes the diagnosis of temporal arteritis in most patients who are suspected of having the disease.

          • When there is strong clinical evidence for temporal arteritis and the ESR is normal, further efforts to diagnose temporal arteritis are required.

          ii. A careful history and physical examination are the most reliable means of making a diagnosis of rheumatoid arthritis. In patients with an equivocal examination, an ESR may be indicated and an abnormal result is a clue to the presence of this disease.

          iii. The ESR may be indicated in the differential diagnosis of solitary bone lesions.

          iv. The ESR may be indicated in the diagnosis of metastatic breast cancer.

          v. The ESR may be indicated as a means of excluding suspected vertebral osteomyelitis.

          vi. The ESR may assist in the differential diagnosis of certain infectious, inflammatory, and malignant disorders.

          vii. The ESR may provide assistance in distinguishing spinal pain of organic origin from mechanical origin.

        3. Monitoring

          i. The ESR is useful for monitoring temporal arteritis and polymyalgia rheumatica.

          ii. The judicious use of the ESR combined with other clinical and laboratory observations may be of value in patients with rheumatoid arthritis and systemic lupus erythematosus.

          iii. The ESR may be indicated for monitoring patients with Hodgkin’s disease.

          iv. The ESR may be indicated for monitoring patients with acute rheumatic fever.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      4. Guidelines for Ordering Biochemical Profiles

        1. Outpatient Screening/Case-Finding

          i. Biochemical profiles are not routinely indicated for screening asymptomatic patients.

          ii. Selected components of biochemical profiles may be indicated for screening and/or case-finding in adults: serum glucose, cholesterol and creatinine.

          iii. Specific components of biochemical profiles that are not indicated for screening include the following: serum calcium, alkaline phosphatase, uric acid, sodium, potassium, chloride, AST, lactic dehydrogenase (LDH), total protein, albumin, and total bilirubin.

          iv. In cases where current technology and/or cost prohibit selective test ordering, biochemical profiles should be used with caution because of a greater likelihood of false-positive findings in low disease-prevalent populations.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      5. Guidelines for Ordering a Serum or Plasma Glucose Test.

        1. Outpatient Screening/Case-Finding

          i. A serum or plasma glucose test is not routinely indicated to screen for diabetes mellitus in asymptomatic, nonpregnant adults.

          ii. A serum or plasma glucose test may be indicated in individuals who are at increased risk for diabetes mellitus.

          • Risk factors for diabetes mellitus include age (>50 years), family history in a first degree relative, personal history of gestational diabetes, body weight that exceeds generally accepted standards by at least 25 percent, or membership in an ethnic group that has a high prevalence of diabetes.

          iii. A serum or plasma glucose test is recommended for all pregnant women to screen for gestational diabetes.

          • A serum or plasma glucose test obtained after a 50-gram glucose load is the preferred screening procedure.

        2. Diagnosis

          i. A fasting or random plasma glucose measurement is useful for the diagnosis of diabetes mellitus in persons who present with symptoms of hyperglycemia (rapid weight loss, polyuria, polydipsia) and/or diabetes (for example, peripheral neuropathy or peripheral vascular disease).

          • An oral glucose tolerance test may be indicated to confirm equivocal tests.

          ii. In patients with clinical findings of hypoglycemia, a serum or plasma glucose should be ordered.

          • The true hypoglycemia syndrome refers to the presence of adrenergic (sweating, tremor, tachycardia, anxiety, and hunger) or neuroglycopenic (dizziness, headache, clouded vision, blunted mental acuity, confusion, abnormal behavior, coma) signs and symptoms in the presence of a low serum or plasma glucose concentration.

        3. Monitoring

          i. A plasma or serum glucose test is not optimal as the primary modality for monitoring glycemia in insulin-dependent (Type I) diabetic patients with diabetes.

          • Daily self-monitored blood glucose measurement, along with periodic (3-4 times per year) measurement of glycated hemoglobin (glycosylated hemoglobin) are appropriate monitoring evaluations

          ii. In non-insulin dependent (Type II) diabetes, laboratory performed plasma or serum glucose testing may be indicated every three months.

          • Self-monitored blood glucose measurement may be indicated one or two times per day to assess glycemia

          • Glycated hemoglobin measurements are indicated at least two times per year to provide an index of mean glucose levels as a measure of overall chronic glucose control

          iii. Laboratory performed fasting and postprandial plasma glucose measurements are indicated in diet-treated gestational diabetes every one to two weeks from time of diagnosis until 30 weeks’ gestation, and once or twice weekly thereafter.

        Rating: Established
        Evidence: Class I, II, III
        Consensus Level: 1
      6. Guidelines for Ordering Serum Urea Nitrogen and Creatinine Test

        1. Outpatient Screening/Case-Finding

          i. Serum urea nitrogen and creatinine tests are not indicated in asymptomatic individuals whose history and physical examination findings are within reference ranges.

          ii. Individuals who have a higher likelihood of developing renal dysfunction may benefit from measuring serum urea nitrogen and creatinine concentrations

          • Patients with hypertension, diabetes mellitus, congestive heart failure, cirrhosis, prostatic hypertrophy, exposure to nephrotoxic agents, taking diuretics, eating a high-protein diet, and over 75 years of age, are candidates for these tests.

        2. Diagnosis

          i. Serum urea nitrogen and creatinine tests are useful in the diagnosis of renal disorders.

          • These tests are indicated in patients with clinical findings suggestive of renal dysfunction, such as pallor, anemia, anorexia, unexplained weight loss, polyuria, urinary hesitancy, nocturia, renal colic, dehydration, retinopathy, hypertension, skin lesions of vasculitis, and/or an abnormal urinalysis (high specific gravity, proteinuria, hematuria, pyuria, presence of crystals and/or casts).

          ii. Measuring serum urea nitrogen and creatinine concentration, or creatinine alone, may be useful in hypertension or diabetes patients.

          iii. Conditions in which both the serum urea nitrogen and creatinine concentration may be indicated include but are not limited to the following:

          • Gastrointestinal bleeding, complicated by some degree of renal insufficiency

          • A suspected diagnosis of water intoxication

          • Syndrome of inappropriate antidiuretic hormone secretion

        3. Monitoring

          i. Measuring serum urea nitrogen and serum creatinine concentration, or creatinine alone, may be useful for the following conditions and at the following frequencies:

          • Uncomplicated hypertensive patients, every one to two years

          • Chronic renal disease, every four to six months

          • Patients in acute renal failure, every one to two days

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      7. Guidelines for Ordering a Serum Calcium Test

        1. Outpatient Screening/Case-Finding

          i. The serum calcium test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum calcium as a screening test for occult metabolic bone disease or malignancy will result in a low diagnostic yield.

          • For most of these conditions, the post-test probability of disease after abnormal calcium results is not sufficiently high to warrant the inclusion of calcium determinations in a screening profile.

        2. Diagnosis

          i. The serum calcium test is useful in the evaluation of patients who present with clinical evidence of hypercalcemia (anorexia, nausea, constipation, polyuria, polydipsia, bone pain, and mental or neurologic aberrations) or hypocalcemia (paresthesias, muscle cramps, tetany, weakness, convulsions).

          ii. The serum calcium test may be useful in the evaluation of patients with hypertension, renal calculi, peptic ulcer disease, metabolic bone disease, malignant disorders, history of previous neck surgery, alcoholism, and acid-base imbalance.

        3. Monitoring

          i. Repeat serum calcium measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Serum calcium may be used to follow the course of hypercalcemia and hypocalcemic disorders and their response to care.

            • A serum calcium level should be interpreted with knowledge of the serum albumin level

          Rating: Established
          Evidence: Class II, III
          Consensus Level: 1
      8. Guidelines for Ordering a Serum Inorganic Phosphorus Test

        1. Outpatient Screening/Case-Finding

          i. The serum inorganic phosphorus test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum inorganic phosphorus as a screening test for various malignant, inflammatory, bony, renal and metabolic disorders will result in a low diagnostic yield.

          • For most of these conditions, the post-test probability of disease after abnormal inorganic phosphorus results is not sufficiently high to warrant the inclusion of inorganic phosphorus determinations in a screening profile.

        2. Diagnosis

          i. The serum inorganic phosphorus test is useful in the evaluation of patients suspected of having metabolic bone disease, renal disorders, endocrime disorders, and acid-base imbalance.

        3. Monitoring

          i. Repeat serum inorganic phosphorus measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Serum inorganic phosphorus may be used to follow the course of hyperphosphatemic and hypophosphatemic disorders and their response to care.

          • A serum inorganic phosphorus level should be interpreted with knowledge of the serum urea nitrogen level.

          Rating: Established
          Evidence: Class II, III
          Consensus Level: 1
      9. Guidelines for Ordering Serum Total Protein and Albumin Test

        1. Outpatient Screening/Case-Finding

          i. The serum total protein and albumin tests are not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum total protein and albumin as screening tests for malnutrition, protein loss or breakdown, and impaired protein synthesis will result in a low diagnostic yield.

        2. Diagnosis

          i. The serum total protein and albumin tests may be useful in the evaluation of patients with suspected malnutrition, liver disorders, renal disease, malabsorption, recurrent infections, blood dyscrasias, and malignancies such as multiple myeloma.

          ii. Results which fall outside the reference range for these tests may require a protein electrophoresis determination and/or immunoelectrophoresis.

        3. Monitoring

          i. Repeat serum total protein and albumin measurements are not indicated in patients in whom no abnormality is suspected.

          ii. Serum total protein and albumin determinations have limited value in monitoring disorders associated with changes in serum protein levels.

          Rating: Established
          Evidence: Class II, III
          Consensus Level: 1
      10. Guidelines for Ordering a Serum Cholesterol Test

        1. Outpatient Screening/Case-Finding

          i. A total serum cholesterol measurement is recommended at least once in early adulthood and at intervals of five or more years up to age 70.

          • The LDL and HDL cholesterol and serum triglyceride levels should be measured in persons with an elevated total serum cholesterol.

          ii. In patients who demonstrate risk factors for coronary artery disese, a serum total cholesterol is indicated to assess cardiac risk.

          • Risk factors for coronary artery disease include: being male or postmenopausal female, positive family history, smoker, hypertension, history of hyper-cholesterolemia, low HDL-cholesterol levels, diabetes mellitus, previous stroke, peripheral vascular disease, or severe obesity.

        2. Diagnosis

          i. The total serum cholesterol is useful in the diagnosis of patients with coronary artery disease and peripheral vascular disease.

          ii. The total serum cholesterol may be useful in the diagnosis of nephrotic syndrome, pancreatitis, and liver disease.

        3. Monitoring

          i. Total serum cholesterol may be used to follow up hypercholesterolemic related disorders and their response to care.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      11. Guidelines for Ordering a Serum Alkaline Phosphatase Test

        1. Outpatient Screening/Case-Finding

          i. The serum alkaline phosphatase test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum alkaline phosphatase as a screening test for unsuspected skeletal and hepatobiliary diseases provides a low diagnostic yield.

          • The pretest probability is low in the general population for those disorders most strongly associated with an elevated alkaline phosphatase.

          • The serum alkaline phosphatase test is not specific for any particular disorder or sensitive enough to identify most patients with any single disease.

        2. Diagnosis

          i. The serum alkaline phosphatase may be useful in the evaluation of patients who present with clinical evidence of a skeletal disorder with increased osteoblastic activity, and are suspected of having either Paget’s disease of bone (osteitis deformans), osteomalacia, primary bone tumors, metastatic bone tumors or primary hyperparathyroidism.

          • Clinical evidence may include backache, bone pain, bone swelling, abnormal plain film bone radiographs, and bone scans.

          ii. The serum alkaline phosphatase test may be useful in the evaluation of patients who present with clinical evidence of a hepatobiliary disorder such as cholelithiasis with obstruction, drug-induced cholestasis, metastatic tumor or space-occupying lesion in the liver, cirrhosis, hepatitis, and alcoholism.

          • Clinical evidence may include fever, nausea, vomiting, abdominal pain, jaundice, certain medication use, and abnormal liver function tests.

          iii. The serum alkaline phosphatase test may exhibit abnormal results in a number of other disorders.

          • These conditions include intestinal disorders, malignancy, malnutrition, congestive heart failure, renal disorders, thyroid dysfunction, diabetes mellitus, and physiological influences (age, pregnancy, non-fasting patient).

        3. Monitoring

          i. Repeat serum alkaline phosphatase measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Periodic determinations of serum alkaline phosphatase may be used to follow the course of a disorder and its response to care.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      12. Guidelines for Ordering Serum Prostatic Acid Phosphatase

        1. Outpatient Screening/Case-Finding

          i. The serum prostatic acid phosphatase test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum prostatic acid phosphatase as a screening test for unsuspected cancer of the prostate provides a low diagnostic yield.

          • Assays for serum prostatic acid phosphatase are not sufficiently sensitive to detect prostatic carcinoma in 70 to 80 percent of patients with localized disease (Stage A or B) or S to 15 percent of patients with metastatic prostatic disease.

          • Specificity is low because nearly every method devised for detecting prostatic acid phosphatase exhibits cross-reactivity with other acid phosphatase isoenzymes found widely in human tissues.

        2. Diagnosis

          i. The serum prostatic acid phosphatase test may be useful in the evaluation of patients with clinical evidence of prostatic carcinoma.

          • Patients may present with obstructive symptoms (hesitancy, diminished urine stream, dribbling, intermittency), lumbar and/or sacral pain, and have induration or nodular irregularities of the prostate discovered by digital rectal examination.

        3. Monitoring

          i. Repeat serum prostatic acid phosphatase measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Serum prostatic acid phosphatase measurement may be used to monitor cancer patients for recurrence after prostatectomy or other ablative care.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      13. Guidelines for Ordering Serum Prostate-Specific Antigen (PSA)

        1. Outpatient Screening/Case-Finding

          i. The serum prostate-specific antigen (PSA) test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum PSA as a screening test for unsuspected cancer of the prostate provides a low diagnostic yield.

          • Serum PSA measurements are not sufficiently sensitive to be used alone as a screening test.

          • The specificity of PSA is limited, due to elevations of the antigen occurring in men with benign prostatic hyperplasia or prostatitis.

        2. Diagnosis

          i. The serum prostate-specific antien is a useful test in the evaluation of patients with clinical evidence of prostatic carcinoma.

          • Serum PSA measurement is a useful addition to rectal examination and ultrasonography in the detection of prostate cancer.

          • PSA is more sensitive but less specific than prostatic acid phosphatase for prostatic cancer.

        3. Monitoring

          i. Repeat serum prostate-specific antigen measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Serum PSA measurements may be useful to detect recurrences of prostate cancer.

          iii. Serum PSA measurements may be useful in monitoring the response to care for prostate cancer.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      14. Guidelines for Ordering a Serum Aspartate Aminotransferase (AST) Test

        NOTE: This test was formerly known as glutamic-oxaloacetic transaminase (SGOT).

        1. Outpatient Screening/Case-Finding

          i. The serum AST is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum AST as a sreening test for liver disorders, cardiac disease, and skeletal muscle disorders will result in a low diagnostic yield.

        2. Diagnosis

          i. The serum AST test may be useful in the evaluation of patients with suspected liver disorders.

        3. Monitoring

          i. Repeat serum AST measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Serum AST may be used to follow the course of various liver disorders and their response to care.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      15. Guidelines for Ordering Serum Creatine Kinase (CK)

        NOTE: This test was formerly known as Creatine Phosphokinase (CPK).

        1. Outpatient Screening/Case-Finding

          i. The serum creatine kinase (CK) test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of the serum creatine kinase (CK) as a screening test for cardiac, skeletal muscle, and central nervous system disorders will result in a low diagnostic yield.

        2. Diagnosis

          i. The serum creatine kinase (CK) test is useful in the evaluation of patients who present with clinical evidence of acute myocardial infarction.

          • Fractionation and measurement of CK isoenzymes (CK-MB primarily) augments total CK results.

          ii. The serum creatine kinase (CK) test may be useful in the differential diagnosis of chest pain, hypothyroidism and in the detection of skeletal muscle disorders that are not of neurogenic origin, such as Duchenne Muscular Dystrophy.

        3. Monitoring

          i. Measurement of serial levels of serum CK and CK-MB isoenzymes are used to monitor care in acute myocardial infarction.

          ii. Total serum CK may be used to follow patients with certain primary myopathies.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      16. Guidelines for Ordering Thyroid Function Tests

        1. Outpatient Screening/Case-Finding

          i. Routine testing for thyroid disorders is not indicated in asymptomatic individuals.

          ii. Case-finding is indicated in women over 50 years of age who have general symptoms that could be associated with thyroid dysfunction.

        2. Diagnosis

          i. The sensitive thyrotropin assay (sTSH) is useful in the evaluation of patients of either sex who present with clinical evidence of thyroid dysfunction.

          • If sTSH is not available, the Free T3, Free T4, or Free T4 Index can be used in the evaluation of suspected hyperthyroidism.

          • For the diagnosis of hypothyroidism, the Free T4 or Free T4 Index, followed by a serum thyrotropin (TSH) test, is acceptable. For patients suspected of having thyroiditis, antithyroid antibody studies may be useful.

        3. Monitoring

          i. The sTSH test is indicated for monitoring patient response to care.

          Rating: Established
          Evidence: Class I, II, III
          Consensus Level: 1
      17. Guidelines for Ordering a Serum Uric Acid Test

        1. Outpatient Screening/Case-Finding

          i. The serum uric acid test is not indicated in asymptomatic individuals whose history and physical examination findings are within reference limits for age and sex.

          ii. The use of serum uric acid as a screening test for gout will provide a low diagnostic yield.

          • On the basis of established prevalences, if asymptomatic individuals were screened, those with an elevated uric acid have only a 5 percent chance of having gout

          iii. For case finding, with a pretest probability of 10 percent (prevalence of gout in the U.S. is estimated at 0.3%), the probability that a correct diagnosis will be derived from a positive test is less than 50%.

        2. Diagnosis

          i. The serum uric acid test is useful in the evaluation of patients who present with clinical evidence of monoarticular arthritis and are suspected of having gout.

            • Gout is a disorder of purine metabolism where the presence of an elevated serum uric acid level is but one of several criteria necessary for diagnosis.

            ii. The serum uric acid test may be elevated in a number of disorders other than gout which affect urate production or excretion, or both.

            • These conditions include: (1) increased nucleic acid turnover related to hematological disorders, malignancy and psoriasis; (2) reduced excretion due to renal dysfunction, certain drugs, and organic acidosis, and (3) miscellaneous causes such as arteriosclerosis and hypertension.

            iii. Serum uric acid measurement is not useful as a test for renal function because the reference range is wide and the rise in uric acid in renal dysfunction is not constant.

        3. Monitoring

          i. Repeat serum uric acid measurement is not indicated in patients in whom no abnormality is suspected.

          ii. Periodic determinations of serum uric acid may be useful in monitoring patients under care for gout.

          iii. Serial serum uric acid analyses are sometimes of value in estimating prognosis in toxemia of pregnancy.

          Rating: Established
          Evidence: Class I, II, III